A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LPA / line probe assay

[Related PubMed/MEDLINE]
Total Number of Papers: 60
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LPA  (>> Co-occurring Abbreviation)
Long Form:   line probe assay
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review. CPA, LAMP, PCR, SAT
2019 Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation. DST, LJ, MDR, TB
2018 Cost analysis of rapid diagnostics for drug-resistant tuberculosis. DST, PSQ, TB, TTR, XDR-TB
2018 Evaluation of line-probe assay for molecular analysis and drug susceptibility of extra-pulmonary tuberculosis. EPTB, PCR, TB
2018 Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India. DST, MDR, RMP
2018 Molecular characterization of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Khartoum, Sudan. DST, MDR, Mtb, NRL, PM, SRL
2018 Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates. LJ, MDR-TB, RIF, WGS
2018 Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect. ---
2017 Band pattern analysis of mutations in rifampicin resistance strain of Mycobacterium tuberculosis by Line Probe assay in patients from Delhi, India. Arg, IRL
10  2017 Diagnosis of tuberculous meningitis: Current scenario from a Tertiary Neurocare Centre in India. CSF, MDR-TB, TBM
11  2017 Diagnostic performance of automated liquid culture and molecular line probe assay in smear-negative pulmonary tuberculosis. ALC, DST, PTB
12  2017 Drug resistance detection and mutation patterns of multidrug resistant tuberculosis strains from children in Delhi. RIF
13  2017 Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India. DST, IRL, pre-XDR-TB
14  2017 Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. EPHI, MDR-TB, NTRL, RMP
15  2017 Evaluation of the AID carbapenemase line probe assay for rapid detection and identification of carbapenemase genes in Gram-negative bacilli. GNB
16  2017 Evaluation of the line probe assay for the rapid detection of bacterial meningitis pathogens in cerebrospinal fluid samples from children. CSF, Hib, PCR
17  2017 GenoType MTBDRplus assay for screening and characterization of isoniazid and rifampicin resistance-associated mutations in multidrug-resistant Mycobacterium tuberculosis from India. MDR, MDR-TB
18  2017 Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana. DST, MTBC, NTM, TB, WHO
19  2017 High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India. CbNAAT
20  2017 Line probe assay for detection of Mycobacterium tuberculosis complex: An experience from Central India. AFB, MDR-TB
21  2017 Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus. INH, MDR-TB, RIF
22  2017 Ocular mycobacteriosis-dual infection of M. tuberculosis complex with M. fortuitum and M. bovis. AFB, ATT, LJ, MGIT, NTM, PCR, RAP
23  2017 Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. ---
24  2017 Public health relevance of non-tuberculous mycobacteria among AFB positive sputa. AFB, Mtb, NTM
25  2017 Rapid laboratory diagnosis of pulmonary tuberculosis. LAMP, NPV, PPV, PTB, TB, ZN
26  2017 Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis. DR-TB, SSM, TB
27  2017 Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa. DST
28  2017 [Diagnosis value with Xpert Mtb/RIF assay for cervical tuberculous lymphadenitis]. ---
29  2016 Detection of rifampicin resistance in tuberculosis by molecular methods: A report from Eastern Uttar Pradesh, India. CBNAAT, TB
30  2016 Discordance between GeneXpert assay and conventional drug-susceptibility testing in detecting rifampicin-resistant tuberculosis: A perspective of the line probe assay. AFB, DST, GM, NTM, RR-TB, RS, TB
31  2016 Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India. DST, MDR-TB, PMDT, RR-TB, UP
32  2016 The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia. LJ, MDR, TB
33  2016 Use and evaluation of a line probe assay in patients with tuberculosis in Peru: 2011-2013. CDST, TB
34  2015 Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa. MDR-TB
35  2015 Evaluation of use of line probe assay on smear-positive direct specimen from extra-pulmonary tuberculosis site. DST, EP, Mtb, TB
36  2015 Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India. MDR-TB, RMP, TB
37  2015 Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa. HIV, IQR, RR-TB, TTT
38  2015 Multidrug-resistant tuberculosis among different types of suspected cases: Study from New Delhi. MDR-TB, PMDT
39  2015 Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. AMK, CAP, KAN, MODS, MOX, OFX, PSQ, RIF
40  2015 Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar. MDR-TB, RIF
41  2015 Rapid detection of rifampicin resistance in Mycobacterium tuberculosis by high-resolution melting curve analysis. HRMA, RMP, RRDR
42  2015 Systematic screening for drug-resistant tuberculosis with Xpert() MTB/RIF in a referral hospital in Cambodia. DST, MDR-TB, RMP
43  2015 Utility of Line Probe Assay for the Early Detection of Multidrug-Resistant Pulmonary Tuberculosis. AFB, DST, LJ, MDR, PM, ZN
44  2014 A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens. LJ
45  2014 Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. ---
46  2014 Evaluation of gene mutations involved in drug resistance in mycobacterium tuberculosis strains derived from tuberculosis patients in mazandaran, iran, 2013. CTAB
47  2014 Impact of introducing the line probe assay on time to treatment initiation of MDR-TB in Delhi, India. ---
48  2014 Molecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in Bangladesh. DST, MDR, MDR-TB, TB
49  2014 Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl. MDR-TB, pre-XDR
50  2014 Rapid Detection of Rifampicin and Isoniazid Resistant Mycobacterium tuberculosis Using Genotype MTBDRplus Assay in Nepal. DST, MDR, TB
51  2014 Stepwise implementation of a new diagnostic algorithm for multidrug-resistant tuberculosis in Haiti. MDR-TB
52  2013 Can inhA mutation predict ethionamide resistance? ETH, INH
53  2013 Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. AFB, DST, LJ, MDR-TB, RIF
54  2013 Detection of drug resistant Mycobacterium tuberculosis among patients with and without HIV infection in a rural setting. MDR, NRA, RIF, TB
55  2013 Genotype diversity of Mycobacterium isolates from children in Jimma, Ethiopia. AFB, DR, EA, EAI, IO, MDR-TB, mPCR, NTM, RDs, RIF, TB
56  2013 Utility of the REBA MTB-Rifa assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis. DST, M. tuberculosis, MDR-TB, RIF, RRDR, TB
57  2012 Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. AMK, CI, DST, OFX
58  2012 Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains. PGM
59  2011 Evaluation of the Genotype MTBDRplus assay as a tool for drug resistance surveys. CTRL, DST, MDR, RMP, SRL, TB
60  2011 Implementation of the INNO-LiPA Rif. TB line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. DST, LJ, MDR-TB, RMP, TB